Page last updated: 2024-11-07

prednisone and Myelomonocytic Leukemia, Chronic

prednisone has been researched along with Myelomonocytic Leukemia, Chronic in 8 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19902 (25.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Meng, J1
Chen, L1
Hou, J1
Chi, H1
Wang, Z1
Yang, C1
Su, Y1
Hilmi, M1
Bally, C1
Burns, R1
Lorillon, G1
Bergeron, A1
Fenaux, P2
Ades, L1
Fain, O1
Gérin, M1
Bibi-Triki, T1
Braun, T1
Rodriguez, V1
Anderson, PM1
Trotz, BA1
Arndt, CA1
Allen, JA1
Khan, SP1
Harris, NL1
Demirjian, Z1
Heyll, A1
Derigs, G1
López-Guillermo, A2
Cervantes, F2
Sacanella, E1
Florensa, L2
Rozman, C2
Ribera, JM1
Feliu, E1

Reviews

2 reviews available for prednisone and Myelomonocytic Leukemia, Chronic

ArticleYear
Probable catastrophic antiphospholipid syndrome secondary to chronic myelomonocytic leukaemia in an adult patient and a mini review.
    Lupus, 2020, Volume: 29, Issue:10

    Topics: Antiphospholipid Syndrome; Bone Marrow; Computed Tomography Angiography; Humans; Hydroxychloroquine;

2020
Use of infliximab-daclizumab combination for the treatment of acute and chronic graft-versus-host disease of the liver and gut.
    Pediatric blood & cancer, 2007, Volume: 49, Issue:2

    Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; A

2007

Other Studies

6 other studies available for prednisone and Myelomonocytic Leukemia, Chronic

ArticleYear
Favorable evolution of lung interstitial disease in a patient with chronic myelomonocytic leukemia treated with azacitidine.
    Annals of hematology, 2018, Volume: 97, Issue:3

    Topics: Antimetabolites, Antineoplastic; Azacitidine; Combined Modality Therapy; Drug Resistance; Humans; Hy

2018
[Relapsing polychondritis and chronic myelomonocytic leukemia].
    La Revue du praticien, 2009, Dec-20, Volume: 59, Issue:10

    Topics: Blast Crisis; Glucocorticoids; Humans; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Polycho

2009
Plasmacytoid T-zone cell proliferation in a patient with chronic myelomonocytic leukemia. Histologic and immunohistologic characterization.
    The American journal of surgical pathology, 1991, Volume: 15, Issue:1

    Topics: Antibodies, Monoclonal; Antigens, CD; Bone Marrow; Cell Transformation, Neoplastic; Female; Humans;

1991
Chronic myelomonocytic leukemia: clinical data, morphological features, and outcome in 56 patients.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Biomarkers, Tumor; Blast Crisis; Bone Marrow; Cytarabine; Germany, West; Hemorrhage; Humans; Leukemi

1990
Pure red cell aplasia associated with chronic myelomonocytic leukaemia.
    Clinical and laboratory haematology, 1989, Volume: 11, Issue:4

    Topics: Aged; Blood Transfusion; Cyclophosphamide; Humans; Leukemia, Myelomonocytic, Chronic; Male; Mercapto

1989
[Erythroblastopenia associated with chronic myelomonocytic leukemia].
    Sangre, 1989, Volume: 34, Issue:4

    Topics: Aged; Anemia; Bone Marrow; Erythroblasts; Humans; Leukemia, Myelomonocytic, Chronic; Male; Mercaptop

1989